Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc. Cannabis Investing News
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets Biotech Investing
UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as COO Pharmaceutical Investing
Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline Pharmaceutical Investing
